MXPA05008425A - Regimen of administration for nelfinavir. - Google Patents

Regimen of administration for nelfinavir.

Info

Publication number
MXPA05008425A
MXPA05008425A MXPA05008425A MXPA05008425A MXPA05008425A MX PA05008425 A MXPA05008425 A MX PA05008425A MX PA05008425 A MXPA05008425 A MX PA05008425A MX PA05008425 A MXPA05008425 A MX PA05008425A MX PA05008425 A MXPA05008425 A MX PA05008425A
Authority
MX
Mexico
Prior art keywords
nelfinavir
regimen
administration
mammal
hiv
Prior art date
Application number
MXPA05008425A
Other languages
Spanish (es)
Inventor
Edward Fu Ceayong Pun
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MXPA05008425A publication Critical patent/MXPA05008425A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The invention relates to a method of treating human immunodeficiency virus (HIV) in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of nelfinavir in a pharmaceutical composition, wherein the nelfinavir is administered with food.
MXPA05008425A 2003-02-10 2004-01-29 Regimen of administration for nelfinavir. MXPA05008425A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44644403P 2003-02-10 2003-02-10
US52425803P 2003-11-21 2003-11-21
PCT/IB2004/000313 WO2004069251A1 (en) 2003-02-10 2004-01-29 Regimen of administration for nelfinavir

Publications (1)

Publication Number Publication Date
MXPA05008425A true MXPA05008425A (en) 2005-10-19

Family

ID=32853430

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008425A MXPA05008425A (en) 2003-02-10 2004-01-29 Regimen of administration for nelfinavir.

Country Status (13)

Country Link
EP (1) EP1605942A1 (en)
JP (1) JP2006517221A (en)
AR (1) AR043133A1 (en)
BR (1) BRPI0407174A (en)
CA (1) CA2515095A1 (en)
CL (1) CL2004000202A1 (en)
MX (1) MXPA05008425A (en)
NL (1) NL1025449C2 (en)
PA (1) PA8595301A1 (en)
PE (1) PE20040948A1 (en)
TW (1) TW200423922A (en)
UY (1) UY28183A1 (en)
WO (1) WO2004069251A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157455B2 (en) 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives

Also Published As

Publication number Publication date
CA2515095A1 (en) 2004-08-19
AR043133A1 (en) 2005-07-20
BRPI0407174A (en) 2006-02-07
EP1605942A1 (en) 2005-12-21
PE20040948A1 (en) 2004-12-27
CL2004000202A1 (en) 2005-03-18
PA8595301A1 (en) 2005-08-04
JP2006517221A (en) 2006-07-20
TW200423922A (en) 2004-11-16
WO2004069251A1 (en) 2004-08-19
NL1025449A1 (en) 2004-08-12
UY28183A1 (en) 2004-09-30
NL1025449C2 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
MY141025A (en) Dose forms
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
MD4430C1 (en) Compositions and methods for treating hepatitis C virus
CO5251419A1 (en) NANOPARTICULATED COMPOSITIONS OF EPLERENONA
WO2006044968A3 (en) Combination therapy for treating viral infections
ATE364595T1 (en) PYRIDOXINE AND PYRIDOXAL ANALOGS AS CARDIOVASCULAR THERAPEUTICS
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
HK1068606A1 (en) Novel aminobenzoephenones
JP2002528502A5 (en)
WO2002034284A3 (en) Methods of therapy for hiv infection
MX2022006742A (en) Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives.
ATE413187T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU
MD2549F1 (en) Method of treatment of the chronic viral hepatitis C
MXPA05008425A (en) Regimen of administration for nelfinavir.
WO2008030853A3 (en) Combination therapy for human immunodeficiency virus infection
EP1583545A4 (en) Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy
RU2013129824A (en) NEW TREATMENT OF HEPATITIS C VIRUS INFECTION
WO2005058248A3 (en) A method of treating hiv infection in atazanavir resistant patients using a combination of atazanavir and another protease inhibitor
MD3121F1 (en) Method of viral hepatitis B prophylaxis
RU2013148539A (en) ALISPORIVIR FOR TREATMENT OF HEPATITIS C VIRUS INFECTION
RU2014116988A (en) ALISPORIVIR FOR TREATING INFECTIONS CAUSED BY HEPATITIS C VIRUS
HUP0301026A2 (en) Use of arginine the preparation of a medicament for the prevention and treatment the side effects associated with the intravenous administration of pharmaceuticals
DOP2004000815A (en) TREATMENT METHOD WITH NELFINAVIR
AU2003219101A8 (en) Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein